1. APPLICATION OF a GENE EXPRESSION‐BASED MODEL IN COMBINATION WITH FDG‐PET IMAGING TO PREDICT TREATMENT RESPONSE IN ADVANCED HODGKIN LYMPHOMA IN THE RATHL STUDY (CRUK/07/033). (June 2017) Authors: Burton, C.H.; Scott, D.; Kirkwood, A.A.; Gandhi, M.; Radford, J.; Barrington, S.; Federico, M.; Luminari, S.; Trotman, J.; Berkhan, L.; D'Amore, F.A.; Kamp, P.; Enblad, G.; Molin, D.; Chalkley, R.; Smith, P.; Stevens, L.; Roberts, T.; Patrick, P.; Chan, F. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CAN BASELINE PET‐CT FEATURES PREDICT OUTCOMES IN ADVANCED HODGKIN LYMPHOMA? A PROSPECTIVE EVALUATION OF UK PATIENTS IN THE RATHL TRIAL (CRUK/07/033). (June 2017) Authors: Pike, L.C.; Kirkwood, A.A.; Patrick, P.; Radford, J.; Burton, C.; Stevens, L.; Clifton‐Hadley, L.; Johnson, P.W.; Barrington, S.F. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EXCELLENT OUTCOMES USING RITUXIMAB, GEMCITABINE, CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISOLONE (R‐GCVP) IN PATIENTS WITH DLBCL AND CARDIAC COMORBIDITIES. (12th June 2019) Authors: Michalarea, V.; Low, R.; Kirkwood, A.A.; Harrington, P.; Yadollahi, S.; Djebbari, F.; Gleeson, M.; Cwynarski, K.; Lambert, J.; Chau, I.; Wrench, D.; Eyre, T.A.; Davies, A.; Ardeshna, K.M.; Cunningham, D.; Fields, P. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 425 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗